Steven A Porcelli Selected Research

KRN 7000 (KRN7000)

12/2020	Amide-Linked C4″-Saccharide Modification of KRN7000 Provides Potent Stimulation of Human Invariant NKT Cells and Anti-Tumor Immunity in a Humanized Mouse Model.
3/2007	Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven A Porcelli Research Topics

Disease

32	Tuberculosis (Tuberculoses) 01/2022 - 07/2002
20	Neoplasms (Cancer) 01/2021 - 07/2003
20	Infections 12/2020 - 08/2003
5	Inflammation (Inflammations) 01/2022 - 09/2004
5	Communicable Diseases (Infectious Diseases) 01/2019 - 03/2004
4	Asthma (Bronchial Asthma) 01/2021 - 02/2007
2	Nasal Polyps (Nasal Polyp) 01/2022 - 01/2021
2	Starvation 01/2021 - 04/2008
2	Sepsis (Septicemia) 01/2021 - 02/2004
2	Virus Diseases (Viral Diseases) 01/2020 - 07/2004
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 11/2005
2	Disease Progression 02/2007 - 07/2005
2	Leprosy (Hansen's Disease) 03/2005 - 03/2004
2	Autoimmune Diseases (Autoimmune Disease) 01/2003 - 06/2002
1	Hypersensitivity (Allergy) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Rhinosinusitis 01/2021
1	Aspirin-Induced Asthma 01/2021
1	Polyps 01/2019
1	Intestinal Polyps 01/2019
1	Zika Virus Infection 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 02/2016
1	Malaria 09/2015
1	HIV Infections (HIV Infection) 01/2014
1	Dyslipidemias (Dyslipidemia) 09/2010

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 01/2022 - 08/2003
11	CytokinesIBA 01/2021 - 07/2004
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
9	Galactosylceramides (Galactocerebrosides)IBA 01/2021 - 02/2011
9	GlycolipidsIBA 01/2021 - 07/2002
9	LipidsIBA 10/2018 - 07/2002
8	AntigensIBA 01/2021 - 01/2003
6	alpha-galactosylceramideIBA 08/2007 - 07/2003
5	LigandsIBA 01/2019 - 07/2004
4	AntibodiesIBA 01/2021 - 02/2007
3	BCG Vaccine FDA Link 01/2016 - 02/2012
3	AerosolsIBA 01/2013 - 08/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 03/2007
2	Tuberculosis VaccinesIBA 01/2021 - 04/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 04/2009
2	EpitopesIBA 01/2021 - 01/2020
2	KRN 7000 (KRN7000)IBA 12/2020 - 03/2007
2	Peptides (Polypeptides)IBA 01/2013 - 03/2005
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 07/2010
2	Interleukin-12 (IL 12)IBA 06/2008 - 10/2004
2	Mycolic Acids (Mycolic Acid)IBA 06/2008 - 03/2007
2	Interleukin-13IBA 09/2007 - 07/2004
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2007 - 09/2004
2	Interleukin-4 (Interleukin 4)IBA 03/2007 - 07/2004
1	Pharmaceutical PreparationsIBA 01/2022
1	Cyclooxygenase 1IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	ChemokinesIBA 01/2021
1	HaptensIBA 01/2021
1	Methionine (L-Methionine)FDA Link 01/2021
1	AmidesIBA 12/2020
1	Interleukin-2 (IL2)IBA 12/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	4-hydroxy-3-methyl-2-butenyl diphosphateIBA 01/2019
1	C-glycosideIBA 01/2019
1	GlycosphingolipidsIBA 01/2019
1	ClathrinIBA 01/2018
1	bafilomycin A1IBA 01/2018
1	safingol (sphinganine)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Chlorpromazine (Thorazine)FDA Link 01/2018
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2018
1	Peptide LibraryIBA 01/2018
1	EstersIBA 01/2018
1	SugarsIBA 01/2018
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2018
1	Inositol (Myoinositol)IBA 07/2017
1	MannosidesIBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Prealbumin (Transthyretin)IBA 02/2016
1	Lipoproteins (Lipoprotein)IBA 09/2014
1	Lysine (L-Lysine)FDA Link 01/2011
1	Attenuated VaccinesIBA 01/2011
1	Interleukin-1 (Interleukin 1)IBA 07/2010
1	Interleukin-6 (Interleukin 6)IBA 07/2010
1	DPPE-PEG2000IBA 02/2010
1	Interleukin-12 Subunit p40IBA 06/2008
1	Tryptophan (L-Tryptophan)FDA Link 04/2008

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2005
7	Immunotherapy 01/2021 - 08/2007
1	Injections 01/2021
1	Ligation 01/2021
1	Punctures 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Aftercare (After-Treatment) 01/2017